-
1.
公开(公告)号:US20220016020A1
公开(公告)日:2022-01-20
申请号:US17449701
申请日:2021-10-01
发明人: Kazuhisa SUGIMOTO , Haruyo SAMBE
IPC分类号: A61K8/9789 , A61Q17/00 , A61Q19/00
摘要: Provided is method of maintaining or improving a skin barrier function in a subject comprising orally administering to the subject a composition comprising an oil-soluble extract from red paprika, wherein the oil-soluble extract contains a hexane-soluble component.
-
2.
公开(公告)号:US20140023602A1
公开(公告)日:2014-01-23
申请号:US14036294
申请日:2013-09-25
CPC分类号: A61K8/73 , A61K8/498 , A61K8/60 , A61Q17/04 , A61Q19/007 , A61Q19/02 , A61Q19/08 , A61Q19/10
摘要: Provided is an external preparation for skin, comprising a phosphorylated saccharide. The phosphorylated saccharide may be an inorganic salt of a phosphorylated saccharide. The phosphorylated saccharide may be a calcium, magnesium, potassium, zinc, iron or sodium salt. Also provided is an external preparation for skin, comprising a phosphorylated saccharide and a second component, wherein the second component is selected from the group consisting of moisturizing agents, whitening components, ultraviolet absorbents, anti-inflammatory agents, cell-activating agents and antioxidants. The moisturizing agent may be ascorbic acid or an ascorbic acid derivative.
摘要翻译: 本发明提供一种皮肤外用剂,其包含磷酸化糖。 磷酸化糖可以是磷酸化糖的无机盐。 磷酸化糖可以是钙,镁,钾,锌,铁或钠盐。 还提供了一种皮肤外用制剂,其包含磷酸化糖和第二组分,其中第二组分选自保湿剂,美白组分,紫外线吸收剂,抗炎剂,细胞活化剂和抗氧化剂。 保湿剂可以是抗坏血酸或抗坏血酸衍生物。
-
3.
公开(公告)号:US20200069568A1
公开(公告)日:2020-03-05
申请号:US16613743
申请日:2018-05-15
发明人: Kazuhisa SUGIMOTO , Haruyo SAMBE
IPC分类号: A61K8/9789 , A61Q19/00 , A61Q17/00
摘要: Provided is a novel agent containing a plant-derived component, which has an effect against the dullness of the skin and an effect against the deterioration of a skin barrier function. A skin dullness suppressing agent or a skin barrier function maintaining or improving agent, which contains an oil-soluble extract derived from red paprika. It is preferred that the skin dullness suppressing agent or the skin barrier function maintaining or improving agent has a dosage form of an oral preparation, and it is also preferred that the oil-soluble extract contains a hexane-soluble component.
-
-